Report Detail
Global Precision Cancer Diagnostic Tests Market Size, Status and Forecast 2019-2025
- RnM3309326 |
- 11 April, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Other
Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves.
In 2018, the global Precision Cancer Diagnostic Tests market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Precision Cancer Diagnostic Tests status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Precision Cancer Diagnostic Tests development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Agilent Technologies, Inc.
Becton Dickinson and Company
Bio-Rad Laboratories, Inc.
Biocartis N.V.
Biocept, Inc.
bioMerieux SA
Canon Medical Systems Corporation
Cynvenio Biosystems, Inc.
Danaher Corporation
Epigenomics AG
Exosome Diagnostics, Inc.
Foundation Medicine, Inc.
General Electric Company
Genomic Health, Inc.
Hologic, Inc.
Illumina, Inc.
Menarini Silicon Biosystems SpA
Myriad Genetics, Inc.
NanoString Technologies, Inc.
Ortho Clinical Diagnostics
QIAGEN N.V.
Randox Laboratories Ltd.
Roche Holding AG
Royal Philips N.V.
Siemens AG
Thermo Fisher Scientific
Vela Diagnostics
Market segment by Type, the product can be split into
Imaging
Molecular
Histology/Cytology
Tumor Marker Immunoassays
POC Colon Cancer Tests
Market segment by Application, split into
Hospital
Clinic
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Precision Cancer Diagnostic Tests status, future forecast, growth opportunity, key market and key players.
To present the Precision Cancer Diagnostic Tests development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Precision Cancer Diagnostic Tests are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Imaging
- 1.4.3 Molecular
- 1.4.4 Histology/Cytology
- 1.4.5 Tumor Marker Immunoassays
- 1.4.6 POC Colon Cancer Tests
- 1.5 Market by Application
- 1.5.1 Global Precision Cancer Diagnostic Tests Market Share by Application (2014-2025)
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Precision Cancer Diagnostic Tests Market Size
- 2.2 Precision Cancer Diagnostic Tests Growth Trends by Regions
- 2.2.1 Precision Cancer Diagnostic Tests Market Size by Regions (2014-2025)
- 2.2.2 Precision Cancer Diagnostic Tests Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Precision Cancer Diagnostic Tests Market Size by Manufacturers
- 3.1.1 Global Precision Cancer Diagnostic Tests Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Precision Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
- 3.2 Precision Cancer Diagnostic Tests Key Players Head office and Area Served
- 3.3 Key Players Precision Cancer Diagnostic Tests Product/Solution/Service
- 3.4 Date of Enter into Precision Cancer Diagnostic Tests Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Precision Cancer Diagnostic Tests Market Size by Type (2014-2019)
- 4.2 Global Precision Cancer Diagnostic Tests Market Size by Application (2014-2019)
5 United States
- 5.1 United States Precision Cancer Diagnostic Tests Market Size (2014-2019)
- 5.2 Precision Cancer Diagnostic Tests Key Players in United States
- 5.3 United States Precision Cancer Diagnostic Tests Market Size by Type
- 5.4 United States Precision Cancer Diagnostic Tests Market Size by Application
6 Europe
- 6.1 Europe Precision Cancer Diagnostic Tests Market Size (2014-2019)
- 6.2 Precision Cancer Diagnostic Tests Key Players in Europe
- 6.3 Europe Precision Cancer Diagnostic Tests Market Size by Type
- 6.4 Europe Precision Cancer Diagnostic Tests Market Size by Application
7 China
- 7.1 China Precision Cancer Diagnostic Tests Market Size (2014-2019)
- 7.2 Precision Cancer Diagnostic Tests Key Players in China
- 7.3 China Precision Cancer Diagnostic Tests Market Size by Type
- 7.4 China Precision Cancer Diagnostic Tests Market Size by Application
8 Japan
- 8.1 Japan Precision Cancer Diagnostic Tests Market Size (2014-2019)
- 8.2 Precision Cancer Diagnostic Tests Key Players in Japan
- 8.3 Japan Precision Cancer Diagnostic Tests Market Size by Type
- 8.4 Japan Precision Cancer Diagnostic Tests Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Precision Cancer Diagnostic Tests Market Size (2014-2019)
- 9.2 Precision Cancer Diagnostic Tests Key Players in Southeast Asia
- 9.3 Southeast Asia Precision Cancer Diagnostic Tests Market Size by Type
- 9.4 Southeast Asia Precision Cancer Diagnostic Tests Market Size by Application
10 India
- 10.1 India Precision Cancer Diagnostic Tests Market Size (2014-2019)
- 10.2 Precision Cancer Diagnostic Tests Key Players in India
- 10.3 India Precision Cancer Diagnostic Tests Market Size by Type
- 10.4 India Precision Cancer Diagnostic Tests Market Size by Application
11 Central & South America
- 11.1 Central & South America Precision Cancer Diagnostic Tests Market Size (2014-2019)
- 11.2 Precision Cancer Diagnostic Tests Key Players in Central & South America
- 11.3 Central & South America Precision Cancer Diagnostic Tests Market Size by Type
- 11.4 Central & South America Precision Cancer Diagnostic Tests Market Size by Application
12 International Players Profiles
- 12.1 Abbott Laboratories
- 12.1.1 Abbott Laboratories Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Precision Cancer Diagnostic Tests Introduction
- 12.1.4 Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
- 12.1.5 Abbott Laboratories Recent Development
- 12.2 Agilent Technologies, Inc.
- 12.2.1 Agilent Technologies, Inc. Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Precision Cancer Diagnostic Tests Introduction
- 12.2.4 Agilent Technologies, Inc. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
- 12.2.5 Agilent Technologies, Inc. Recent Development
- 12.3 Becton Dickinson and Company
- 12.3.1 Becton Dickinson and Company Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Precision Cancer Diagnostic Tests Introduction
- 12.3.4 Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
- 12.3.5 Becton Dickinson and Company Recent Development
- 12.4 Bio-Rad Laboratories, Inc.
- 12.4.1 Bio-Rad Laboratories, Inc. Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Precision Cancer Diagnostic Tests Introduction
- 12.4.4 Bio-Rad Laboratories, Inc. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
- 12.4.5 Bio-Rad Laboratories, Inc. Recent Development
- 12.5 Biocartis N.V.
- 12.5.1 Biocartis N.V. Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Precision Cancer Diagnostic Tests Introduction
- 12.5.4 Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
- 12.5.5 Biocartis N.V. Recent Development
- 12.6 Biocept, Inc.
- 12.6.1 Biocept, Inc. Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Precision Cancer Diagnostic Tests Introduction
- 12.6.4 Biocept, Inc. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
- 12.6.5 Biocept, Inc. Recent Development
- 12.7 bioMerieux SA
- 12.7.1 bioMerieux SA Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Precision Cancer Diagnostic Tests Introduction
- 12.7.4 bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
- 12.7.5 bioMerieux SA Recent Development
- 12.8 Canon Medical Systems Corporation
- 12.8.1 Canon Medical Systems Corporation Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Precision Cancer Diagnostic Tests Introduction
- 12.8.4 Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
- 12.8.5 Canon Medical Systems Corporation Recent Development
- 12.9 Cynvenio Biosystems, Inc.
- 12.9.1 Cynvenio Biosystems, Inc. Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Precision Cancer Diagnostic Tests Introduction
- 12.9.4 Cynvenio Biosystems, Inc. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
- 12.9.5 Cynvenio Biosystems, Inc. Recent Development
- 12.10 Danaher Corporation
- 12.10.1 Danaher Corporation Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Precision Cancer Diagnostic Tests Introduction
- 12.10.4 Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
- 12.10.5 Danaher Corporation Recent Development
- 12.11 Epigenomics AG
- 12.12 Exosome Diagnostics, Inc.
- 12.13 Foundation Medicine, Inc.
- 12.14 General Electric Company
- 12.15 Genomic Health, Inc.
- 12.16 Hologic, Inc.
- 12.17 Illumina, Inc.
- 12.18 Menarini Silicon Biosystems SpA
- 12.19 Myriad Genetics, Inc.
- 12.20 NanoString Technologies, Inc.
- 12.21 Ortho Clinical Diagnostics
- 12.22 QIAGEN N.V.
- 12.23 Randox Laboratories Ltd.
- 12.24 Roche Holding AG
- 12.25 Royal Philips N.V.
- 12.26 Siemens AG
- 12.27 Thermo Fisher Scientific
- 12.28 Vela Diagnostics
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Precision Cancer Diagnostic Tests . Industry analysis & Market Report on Precision Cancer Diagnostic Tests is a syndicated market report, published as Global Precision Cancer Diagnostic Tests Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Precision Cancer Diagnostic Tests market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
